Related Experiment Video
Updated: Sep 11, 2025

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Molecular Windows into the Brain: Advances in BBB-Penetrable NIR Fluorescent Imaging Probes
Haoyu Niu1, Xiaokang Xue1, Mengze Xu1
1Faculty of Arts and Sciences & Center for Advanced Materials Research, Beijing Normal University, Zhuhai 519087, China.
New near-infrared (NIR) fluorescent probes can now cross the blood-brain barrier (BBB), enabling noninvasive imaging for brain diseases like Alzheimer's and Parkinson's. This review details probe design for early diagnosis and better treatments.
Area of Science:
- Neuroscience
- Medical Imaging
- Biochemistry
Background:
- The blood-brain barrier (BBB) limits brain diagnostics and therapeutics.
- Neurological disorders like Alzheimer's disease (AD) and Parkinson's disease (PD) require advanced imaging.
- Near-infrared (NIR) fluorescent probes offer potential for noninvasive brain visualization.
Purpose of the Study:
- To review recent advancements in BBB-penetrable NIR fluorescent probes.
- To discuss design strategies and mechanisms for neurological condition imaging.
- To highlight applications in detecting disease-specific biomarkers.
Main Methods:
- Systematic review of literature on NIR probe development.
- Analysis of probe design, working mechanisms, and BBB penetration.
- Evaluation of probe applications in preclinical and clinical studies.
Main Results:
- NIR probes demonstrate potential for noninvasive in vivo imaging of brain disorders.
- Specific probe designs facilitate BBB crossing and biomarker detection.
- Advances enable imaging of depression, epilepsy, stroke, glioma, AD, and PD.
Conclusions:
- BBB-penetratable NIR probes are crucial for early diagnosis of brain diseases.
- Further development is needed to overcome current limitations for clinical translation.
- NIR probes promise improved therapeutic interventions and patient outcomes.
More Related Videos
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
10:30High-resolution Confocal Imaging of the Blood-brain Barrier: Imaging, 3D Reconstruction, and Quantification of Transcytosis
Published on: November 16, 2017